How we work
Our Health Investments team continuously scopes healthcare markets for new opportunities for our financial products to increase access to medical innovations.
When needed, we call for expressions of interest from suppliers looking to work with us to increase access to their products.
If we have an opportunity that matches your ambitions, please consider submitting an expression of interest. We are keen to hear from you.
Current calls
Call for Expressions of Interest: Long-acting depot-buprenorphine
Summary: Invitation to manufacturers of long-acting depot-buprenorphine (LADB) to submit an expression of interest for financial support to improve affordability of the product and support access in low- and middle-income countries.
Deadline: 15th January 2026
